McKesson (MCK) said Tuesday it has agreed to acquire a controlling interest in PRISM Vision Holdings from Quad-C for $850 million
McKesson will retain an 80% stake in the provider of ophthalmology and retina management services, while PRISM Vision physicians will hold the rest.
Upon closing, PRISM Vision is anticipated to add about $0.20 to $0.30 to McKesson's adjusted earnings per diluted share in the first 12 months, and $0.65 to $0.75 by the end of the third year, the company said.
The transaction will add 180 providers, 91 office locations, and seven ambulatory surgery centers to McKesson's platform.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。